Clinical Trials Directory

Trials / Completed

CompletedNCT06078163

Combined Rehabilitation With ALA, ALC, Resveratrol and Vitamin D in Discogenic Sciatica in Young People

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
University of Palermo · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The objective of this Interventional case-control clinical study is to evaluate the effectiveness of physiotherapy combined with the administration of Alpha Lipoic Acid, L-acetylcarnitine, Resvelatrol, Vit D3 in the treatment of sciatica due to herniated disc in young patients. The main questions we intend to answer are: * Is this combined treatment more effective in reducing pain? * Is the combined treatment useful for improving postural alterations, reducing the intake of painkillers and the number of days of absence from work and improving the quality of life?

Conditions

Interventions

TypeNameDescription
OTHERsupplementationdaily pharmacological therapy with Alpha Lipoic Acid 600 mg, L-acetylcarnitine 1000 mg, Resvelatrol 50 mg, vit D3 800UI for 30 consecutive days in combination with a rehabilitation protocol lasting 20 sessions
OTHERrehabilitationrehabilitation protocol lasting 20 sessions.

Timeline

Start date
2022-07-01
Primary completion
2023-03-04
Completion
2023-08-22
First posted
2023-10-11
Last updated
2023-10-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06078163. Inclusion in this directory is not an endorsement.